|
Market Closed -
NSE India S.E.
19:05:10 11/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 523.55 INR | +2.02% |
|
+1.83% | +68.67% |
| 11-05 | SMS Pharmaceuticals Limited, Q2 2027 Earnings Call, Nov 05, 2026 | |
| 11-04 | SMS Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 | CI |
| Market Cap | 48.06B 513M 460M 424M 385M 728M 749M 5.07B 2.02B 25.75B 1.92B 1.88B 81.4B | P/E 2025 |
27.3x | P/E 2026 | 33.6x |
|---|---|---|---|---|---|
| Enterprise Value | 51.25B 547M 490M 452M 410M 777M 798M 5.41B 2.16B 27.46B 2.05B 2.01B 86.81B | EV / Sales 2025 |
2.75x | EV / Sales 2026 | 4.31x |
| Free-Float |
24.01% | Yield 2025 |
0.19% | Yield 2026 | 0.11% |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SMSPHARMA | Delayed | |
Bombay S.E.
| SMSPHARMA | Delayed |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | +2.02% | ||
| 1 week | -0.37% | ||
| Current month | +2.39% | ||
| 1 month | +18.61% | ||
| 3 months | +38.23% | ||
| 6 months | +24.85% | ||
| Current year | +68.67% |
| 1 week | 493.8 |  | 533.5 |
| 1 month | 405 | | 535 |
| Current year | 293.15 | | 535 |
| 1 year | 270.1 | | 535 |
| 3 years | 113.3 | | 535 |
| 5 years | 54.55 | | 535 |
| 10 years | 24 | | 535 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 30/08/1990 | |
| Director of Finance/CFO | - | 13/09/2017 | |
Manohar Mollama
CMP | Compliance Officer | - | 05/11/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 30/08/1990 | |
| Director/Board Member | 38 | 05/06/2020 | |
| Director/Board Member | 48 | 29/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.02% | -0.37% | +79.76% | +334.48% | 513M | |
| +1.44% | +1.63% | +48.17% | +139.63% | 1,276B | |
| -0.47% | +5.49% | +49.03% | +90.68% | 676B | |
| +0.20% | +2.76% | +34.37% | +112.06% | 519B | |
| -0.55% | +0.81% | +38.24% | +67.16% | 388B | |
| -0.48% | +2.34% | +70.66% | +46.02% | 365B | |
| -1.13% | -0.94% | +27.79% | +57.17% | 307B | |
| -0.10% | -1.17% | +2.93% | +35.25% | 287B | |
| 0.00% | +0.86% | +43.74% | +74.04% | 252B | |
| +0.92% | +2.03% | +44.62% | +125.07% | 212B | |
| Average | -0.19% | +2.28% | +43.93% | +108.16% | 428B | |
| Weighted average by Cap. | -0.67% | +2.51% | +42.72% | +96.55% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 7.83B 83.49M 74.87M 69M 62.66M 119M 122M 826M 329M 4.19B 313M 307M 13.26B | 8.89B 94.78M 85M 78.33M 71.14M 135M 138M 938M 374M 4.76B 356M 348M 15.05B |
| Net income | 691M 7.37M 6.61M 6.09M 5.53M 10.47M 10.77M 72.97M 29.07M 370M 27.67M 27.09M 1.17B | 1.02B 10.88M 9.76M 8.99M 8.16M 15.45M 15.88M 108M 42.89M 546M 40.82M 39.96M 1.73B |
| Net Debt | 2.69B 28.72M 25.76M 23.74M 21.56M 40.8M 41.94M 284M 113M 1.44B 108M 105M 4.56B | 3.19B 34.03M 30.52M 28.13M 25.54M 48.34M 49.69M 337M 134M 1.71B 128M 125M 5.4B |
Employees
1,617
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | ₹523.55 | +2.02% | 322,458 |
| 09/11/26 | ₹513.20 | +1.62% | 707,381 |
| 08/11/26 | ₹505.00 | +1.29% | 166,912 |
| 06/11/26 | ₹498.55 | -3.51% | 395,857 |
| 05/11/26 | ₹516.70 | -1.67% | 770,206 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
